Business · 01/12/2017Updated: 10/17/2026 · 1 min read
Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) is withdrawing approval of 68 abbreviated new drug applications (ANDAs) from multiple applicants after they notified the agency that the drug products were no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →